A gene expression profile study of sporadic pancreatic NETs revealed down regulation of TSC2 and PTEN, two key inhibitors of the AKT/mTOR pathway in most of the sporadic NETs. The gene discussed is MTOR; the disease is pancreatic neuroendocrine tumor.